Cytolex MSI-78 1 percent topical antibiotic cream data

MAGN announced results of its second pivotal Phase III equivalence trial of Cytolex (MSI-78) to treat infection of diabetic foot ulcers. The results

Read the full 239 word article

How to gain access

Continue reading with a
two-week free trial.